We are live on ! Find out more
EVGN icon

Evogene
EVGN

23 hedge funds and large institutions have $18.2M invested in Evogene in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0.01% more ownership

Funds ownership: 3.53% → 3.54% (+0.01%)

0% more funds holding

Funds holding: 23 → 23 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

35% less capital invested

Capital invested by funds: $28.2M → $18.2M (-$9.98M)

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$146K
2
Jane Street
Jane Street
New York
+$90.4K
3
UBS Group
UBS Group
Switzerland
+$38.4K
4
Citadel Advisors
Citadel Advisors
Florida
+$35K
5
AIM
ARK Investment Management
Florida
+$24.1K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$153K
2
Morgan Stanley
Morgan Stanley
New York
-$114K
3
Deutsche Bank
Deutsche Bank
Germany
-$25K
4
MIH
Meitav Investment House
Israel
-$22.6K
5
SWM
Stockman Wealth Management
Montana
-$8.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$5.59M – – –
UBS Group
2
UBS Group
Switzerland
$2.61M +$38.4K +1,519 +1%
Bank of America
3
Bank of America
North Carolina
$2.04M +$1.9K +75 +0.1%
CI
4
Clal Insurance
Israel
$1.19M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.13M +$146K +5,785 +11%
MCM
6
Moon Capital Management
New York
$992K +$6.67K +264 +0.5%
Canada Pension Plan Investment Board
7
Canada Pension Plan Investment Board
Ontario, Canada
$833K – – –
Goldman Sachs
8
Goldman Sachs
New York
$727K -$76 -3 -0%
JP Morgan Chase
9
JP Morgan Chase
New York
$682K – – –
MMH
10
Menora Mivtachim Holdings
Israel
$513K – – –
AIM
11
ARK Investment Management
Florida
$499K +$24.1K +955 +4%
DG
12
Delek Group
Israel
$425K – – –
SM
13
Senvest Management
New York
$273K – – –
AS
14
Altshuler Shaham
Israel
$180K – – –
HIIFS
15
Harel Insurance Investments & Financial Services
Israel
$157K – – –
Morgan Stanley
16
Morgan Stanley
New York
$105K -$114K -4,516 -46%
Jane Street
17
Jane Street
New York
$71K +$90.4K +3,577 New
MIH
18
Meitav Investment House
Israel
$39K -$22.6K -895 -31%
Citadel Advisors
19
Citadel Advisors
Florida
$28K +$35K +1,385 New
SWM
20
Stockman Wealth Management
Montana
$25K -$8.34K -330 -21%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$20K – – –
Citigroup
22
Citigroup
New York
$17K – – –
Norges Bank
23
Norges Bank
Norway
$13K – – –
Barclays
24
Barclays
United Kingdom
– -$153K -4,933 Closed
Deutsche Bank
25
Deutsche Bank
Germany
– -$25K -800 Closed

EVGN Hedge Fund Activity: Q4 2018 in Review

23 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2018, worth a combined $18.2M — down 35% from $28.2M a quarter earlier.

Fund positioning in EVGN was balanced in Q4 2018: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $146K. The largest seller was Barclays, exiting entirely with an estimated $153K sold.

  • 23 institutional investors held Evogene (EVGN) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $18.2M of Evogene stock for Q4 2018, down 35% quarter-over-quarter.
  • 2 funds opened new Evogene positions in Q4 2018 and 2 closed out, a net change of 0 holders.
  • The largest Evogene buyer in Q4 2018 was Vanguard Group, an estimated $146K added.
  • The largest Evogene seller in Q4 2018 was Barclays, an estimated $153K sold.

Based on aggregated 13F filings for Q4 2018.